Among all the respondents in June’s Global Business Barometer reading from The Economist Intelligence Unit, executives in the healthcare industry appear the most optimistic.

They are confident that their market share, operational agility and profitability will be ‘somewhat better’, yet they remain pessimistic about revenue growth.

The Barometer also reveals that healthcare and pharmaceutical firms are among those boosting investment or business spending. The Economist Intelligence Unit surmises that those initiatives are going into R&D for viral treatments or front line equipment and drug procurement or sales channel investment.

Date published: August 6, 2020

Continue reading

Subscribe to get unlimited digital access.

Subscribe

Already a subscriber? Login